Form 8-K - Current report:
SEC Accession No. 0001104659-20-067133
Filing Date
2020-05-28
Accepted
2020-05-28 17:07:22
Documents
6
Period of Report
2020-05-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2021141d1_8k.htm 8-K 28477
2 EXHIBIT 1.1 tm2021141d1_ex1-1.htm EX-1.1 231875
3 EXHIBIT 5.1 tm2021141d1_ex5-1.htm EX-5.1 13255
4 EXHIBIT 99.1 tm2021141d1_ex99-1.htm EX-99.1 11900
5 GRAPHIC image_001.jpg GRAPHIC 15690
6 GRAPHIC image_002.jpg GRAPHIC 19900
  Complete submission text file 0001104659-20-067133.txt   336056
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 20922179
SIC: 2834 Pharmaceutical Preparations